KBL Merger Corp. IV (KBLM), filed a definitive proxy this morning for their upcoming shareholder vote to extend their termination date another six months. However, KBLM has further amended the proxy to now reflect a $0.0225 per month contribution for shareholders who do not redeem.
Originally, KBLM agreed to contribute $0.03 for each public share that was not redeemed for each calendar month commencing on June 7, 2019, through September 7, 2019 (should they need the full three months). However, given where KBLM is in their negotiation process with CannBioRx, they are now asking for a potential six months, which would move their potential deadline date to December 7th instead.
KBLM’s preliminary proxy for their June 5th vote (filed 5/8) stated a $0.025 per month contribution, but this is now amended to reflect $0.0225. This change means that should KBLM need the full six months, the total contribution is now $0.135, down from $0.15.
The record date is still May 15th, however, it should be noted that KBLM is requiring shareholders to vote either “for” or “against” the extension proposal in order to redeem. That means that only shareholders of record will be able to redeem for their pro rata per share portion of the trust.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...